Apr 24, 2019 Last Updated 11:27 AM, Mar 29, 2019

High-Risk research pays off, ERC says.

Published in News
Read 374 times
Rate this item
(0 votes)

The European Research Council recently published its annual review regarding funded projects that ended in mid-2015, and declared that around four out of five financed studies resulted in a major scientific advances and, among these, one out of five consisted in a fundamental breakthrough; these studies are already having considerable economic and social impact. 


Quite importantly, according to the reviewers, most of these financed projects were defined as "high risk", strongly suggesting that more risk-friendly policies from funding agencies in Europe represent an important driving force to promote highly-rewarding studies, as well as to retain talents in Europe (where most of research funders are generally "risk-averse").

Source: Nature Website

Last modified on Tuesday, 18 September 2018 10:20
Login to post comments

Registered area

Thanks to the support of
merck serono biogen sanofi

Conferences & Courses

17° Corso CRNI Viva la differenza: sesso e neuroimmunologia

March 7-10, 2018 
Bergamo - Bergamo Science Center


Encefaliti Autoimmuni e Malattie Demielinizzanti Atipiche

16 febbraio 2018
Aula Magna Giorgio De Sandre


JNIInternational Brain Research Organization
Bringing Neuroscience to the World
JNIJournal of Neuroimmunology
Studies on all branches of neurosciences covering both research and clinical problems of neuroscientific interest.

This website or its third party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the cookie policy. By closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies. To find out more about the cookies we use and how to delete them, see our Cookie Policy